Letter: Rifaximin versus low FODMAP diet in IBS: What the primary endpoint does not tell us. Authors' reply
Chuah, Kee Huat, Loo, Qing Yuan, Loh, Audrey Joe Chii, Leong, Jing Yi, Chan, Wah Loong, Khoo, Xin Hui, Wong, Kim Leng, Panirsheeluam, Sarala, Natarajan, Vicraman, Ng, Ai Kah, Majid, Hazreen Abdul and Mahadeva, Sanjiv (2026) Letter: Rifaximin versus low FODMAP diet in IBS: What the primary endpoint does not tell us. Authors' reply. Alimentary Pharmacology & Therapeutics, 63. pp. 909-910. ISSN 1365-2036
![[img]](https://hsu.repository.guildhe.ac.uk/style/images/fileicons/text.png) |
Text
Majid H APT letter combined.pdf - Accepted Version Restricted to Repository staff only until 29 January 2027. Available under License All Rights Reserved . Download (337kB) |
Official URL: https://doi.org/10.1111/apt.70553
| Item Type: | Article |
|---|---|
| Schools: | School of Health and Rehabilitation Sciences |
| Depositing User: | Jessica Tovey |
| Date Deposited: | 15 May 2026 10:31 |
| Last Modified: | 03 Jun 2026 15:35 |
| URI: | https://hsu.repository.guildhe.ac.uk/id/eprint/630 |
Actions (login required)
 |
Edit Item |